Hand over your Humira biosim launch plans, judge tells Boehringer in AbbVie patent fight FiercePharma
In a high-stakes Humira patent fight, AbbVie persuaded a judge to force Boehringer Ingelheim to turn in its biosimilar launch plans. Because if BI is stockpiling …